Abstract 410: Development of novel, non-toxic rifamycins that reverse drug resistance
Maxwell, Steve A., Wallis, Deeann, Zhou, Nian, Baker, Dwight, Mousavi-Fard, Seyed H., Loesch, Kimberly, Galaviz, Stacy, Guthrie, Liam, Snavely, Thomas, Sun, Qingan, Rojas, Carolina M., Threadgill, David W., Ioerger, Thomas, Dong, Wen, Seemann, Gwen, Fossum, Theresa W., Sacchettini, James C.
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article